81 – 90 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Macrophages in inflammatory bowel disease
(
- Contribution to journal › Article
-
Mark
Diverse responses between human pancreatic cancer cell lines to native alpha 1-antitrypsin and its C-terminal fragment.
(
- Contribution to journal › Article
-
Mark
Pravastatin inhibits pro-inflammatory effects of Alzheimer's peptide Abeta(1-42) in glioma cell culture in vitro.
(
- Contribution to journal › Article
-
Mark
Circulating monocytes from healthy individuals and COPD patients.
(
- Contribution to journal › Article
-
Mark
Human mast cells decrease SLPI levels in type II - like alveolar cell model, in vitro.
(
- Contribution to journal › Article
-
Mark
Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
(
- Contribution to journal › Article
- 2002
-
Mark
Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes.
(
- Contribution to journal › Article
-
Mark
Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.
(
- Contribution to journal › Scientific review
-
Mark
Effects of native and cleaved forms of alpha1-antitrypsin on ME 1477 tumor cell functional activity.
(
- Contribution to journal › Article
-
Mark
Alpha1-antichymotrypsin/Alzheimer's peptide Abeta(1-42) complex perturbs lipid metabolism and activates transcription factors PPARgamma and NFkappaB in human neuroblastoma (Kelly) cells.
(
- Contribution to journal › Article